ArticleFrontiers in genetics2021

Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa.

Laura De Rosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.